A line chart shows companies' revenues from 2020 to 2023. Medtronic's is at the top, above $2 billion, while Insulet is the fastest growing. Tandem is at the bottom.
Note: Annual numbers were calculated by adding together the four most recent quarters before Jan. 31. Medtronic's most recent quarter ended on Jan. 26.
Chart: Elise ReuterSource: Company annual reportsGet the dataCreated with Datawrapper